UBE Corporation (TYO:4208)

Achilles Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	115,969	36,359	31,175	79,492	80,304
Cash & Short-Term Investments	115,969	36,359	31,175	79,492	80,304
Cash Growth	218.96%	16.63%	-60.78%	-1.01%	94.79%
Receivables	102,603	101,965	101,456	155,349	149,053
Inventory	121,989	133,948	127,008	124,709	87,834
Other Current Assets	17,816	23,406	23,377	35,139	14,536
Total Current Assets	358,377	295,678	283,016	394,689	331,727
Property, Plant & Equipment	222,701	222,158	208,027	332,757	331,223
Long-Term Investments	252,833	250,471	217,678	85,079	82,358
Goodwill	2,418	1,448	2,952	857	720
Other Intangible Assets	9,244	7,121	4,822	7,684	6,950
Long-Term Deferred Tax Assets	19,752	11,881	14,853	16,452	16,263
Long-Term Deferred Charges	224	155	149	133	173
Total Assets	865,669	789,034	731,636	837,954	769,710
Accounts Payable	48,258	62,068	69,241	110,766	90,831
Accrued Expenses	4,600	5,141	5,258	6,951	6,446
Short-Term Debt	79,834	63,370	58,137	61,506	38,031
Current Portion of Long-Term Debt	10,000	10,000	-	10,000	10,000
Current Portion of Leases	561	518	553	802	785
Current Income Taxes Payable	32,648	32,262	21,727	40,182	33,914
Other Current Liabilities	21,818	24,862	16,243	18,967	20,433
Total Current Liabilities	197,719	198,221	171,159	249,174	200,440
Long-Term Debt	235,646	135,572	155,520	164,670	161,245
Long-Term Leases	4,495	3,972	3,933	4,834	4,706
Long-Term Deferred Tax Liabilities	857	1,430	1,013	1,932	779
Other Long-Term Liabilities	10,100	13,005	10,937	15,595	13,663
Total Liabilities	453,656	359,679	349,977	443,919	389,075
Common Stock	58,435	58,435	58,435	58,435	58,435
Additional Paid-In Capital	40,363	40,370	40,371	40,623	40,659
Retained Earnings	260,914	276,409	257,985	274,725	259,806
Treasury Stock	-21,486	-21,598	-21,676	-22,234	-12,380
Comprehensive Income & Other	56,876	55,135	26,595	18,103	13,040
Total Common Equity	395,102	408,751	361,710	369,652	359,560
Minority Interest	16,911	20,604	19,949	24,383	21,075
Shareholders' Equity	412,013	429,355	381,659	394,035	380,635
Total Liabilities & Equity	865,669	789,034	731,636	837,954	769,710
Total Debt	330,536	213,432	218,143	241,812	214,767
Net Cash (Debt)	-214,567	-177,073	-186,968	-162,320	-134,463
Net Cash Per Share	-2209.89	-1823.56	-1928.10	-1646.78	-1325.75
Filing Date Shares Outstanding	97.12	97.07	97.04	96.86	100.42
Total Common Shares Outstanding	97.12	97.07	97.04	96.81	101.14
Working Capital	160,658	97,457	111,857	145,515	131,287
Book Value Per Share	4068.15	4210.75	3727.41	3818.43	3554.93
Tangible Book Value	383,440	400,182	353,936	361,111	351,890
Tangible Book Value Per Share	3948.07	4122.47	3647.30	3730.20	3479.10
Order Backlog	50,828	57,267	52,229	52,091	53,098

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.